| Announce Date | 10/16/2025 |
| EPS Normalized Actual | $1.22 (Beat by $0.09) |
| EPS GAAP Actual | $1.22 (Beat by $0.09) |
| Revenue Actual | $9.807B |
| Revenue Surprise | Beat by $9807M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.1071 |
| EPS GAAP Estimate | $1.1071 |
| Revenue Estimate | $7.259249676B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 5 | 9.25 | 4.96304 | 5.04419 | 13 |
| Dec 2026 | 4.99378 | 9.27 | 4.45 | 5.75105 | 6 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.22 | 0.14633 | 9.807B | 72.47% | 2654.18M |
| FQ2 2025 (Jun 2025) | 1.11 | 0.02869 | 7.604B | -42.03% | 381.97M |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 10.35B | -1.1% | 10350M |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 6.979B | 3.55% | 6979M |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 2.7B | -159.26% | 2700M |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 10.8B | 33.88% | 10800M |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 10.464B | 31.76% | 10464M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 6.731B | 5.87% | 6731M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.1071
Consensus Revenue Estimates
7.259249676B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.3675 | -- | 1.36292 | 1.37189 | 6 |
| FQ3 2027 (Sep 2027) | 1.3005 | -- | 1.29614 | 1.30468 | 3 |
| FQ2 2027 (Jun 2027) | 1.2668 | -- | 1.26255 | 1.27087 | 3 |
| FQ1 2027 (Mar 2027) | 1.0688 | -- | 1.06522 | 1.07223 | 6 |
| FQ4 2026 (Oct 2026) | 1.2248 | -- | 1.21262 | 1.23592 | 3 |
| FQ3 2026 (Jul 2026) | 1.1587 | -5.29 | 1.14718 | 1.16922 | 3 |
| FQ2 2026 (Jun 2026) | 1.16335 | 4.59 | 1.14966 | 1.18155 | 8 |
| FQ1 2026 (Mar 2026) | 1.0422 | 1.17 | 1.02994 | 1.0585 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 7.45B | -- | 7.43B | 7.46B | 1 |
| FQ3 2027 (Sep 2027) | 7.35B | -- | 7.33B | 7.37B | 1 |
| FQ2 2027 (Jun 2027) | 7.25B | -- | 7.23B | 7.27B | 1 |
| FQ1 2027 (Mar 2027) | 7.16B | -- | 7.14B | 7.18B | 1 |
| FQ4 2026 (Oct 2026) | 11.93B | -- | 11.84B | 12.02B | 4 |
| FQ3 2026 (Jul 2026) | 11.78B | 16.74 | 11.69B | 11.86B | 4 |
| FQ2 2026 (Jun 2026) | 12B | 36.62 | 11.89B | 12.14B | 4 |
| FQ1 2026 (Mar 2026) | 11.84B | 12.59 | 11.73B | 11.98B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.07367 | 1.22 | 0.14633 | 11.99% |
| FQ2 2025 (Jun 2025) | 1.08131 | 1.11 | 0.02869 | 2.58% |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 100% | |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 100% | |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 100% | |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 100% | |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $7.15B | $9.81B | $2654.18M | 27.06% |
| FQ2 2025 (Jun 2025) | $7.22B | $7.6B | $381.97M | 5.02% |
| FQ1 2025 (Mar 2025) | $0B | $10.35B | $10350M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $6.98B | $6979M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.7B | $2700M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $10.8B | $10800M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $10.46B | $10464M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.73B | $6731M | 100% |